Soheil Mansour Sohani
Iran University of Medical Sciences, Tehran, Iran
Abstract Title: The effects of TECAR therapy on pain, range of motion, strength and subscale of HAGOS questionnaire in athletes with chronic adductor related groin pain: a randomized controlled trial
Biography: Soheil Mansour Sohani completed his BSc. In physiotherapy from TUMS, MSc. and Ph.D. from IUMS in Tehran, Iran. He is an associate professor and lecturer at Physiotherapy Dept., School of Rehabilitation Sciences, Iran University of Medical Sciences and Tehran, Iran. He had online presentation in past Online Conferences, October 28-29 2020, titled:” Shockwave Therapy: Radial vs. Focused” and April 12-13 2021, titled:” Radiofrequency in musculoskeletal pain” and October 15-16 2021, titled:” Mulligan concept of manual 2 therapy” and November 28-29 2022, titled: "Light therapy in neuromusculoskeletal pain” and November 18-19 2024, titled: " Low-intensity and extremely low frequency electrostatic fields (deep oscillation).
Research Interest: Methods: This study was a two arm parallel group's randomized sham-controlled superiority trial. A total of 22 male professional athletes (mean age 21.36 years) were randomly assigned to either the real TECAR therapy (n = 11) or sham TECAR therapy (n = 11) group, using block-balanced randomization. Both groups received stretching exercises. Intervention group received 10 sessions of TECAR therapy while, the control group received sham TECAR therapy. Primary outcome was pain that was measured by Visual Analogue Scale (VAS). Secondary outcomes included ROM, strength, and HAGOS questionnaire subscales. All outcomes were assessed at baseline, after 5 sessions, after 10 sessions, and one month after treatment. Analysis of Variance (ANOVA) and Analysis of Covariance were used to compare between-group mean differences. Results A total of 22 male athletes were included (11 in each group), with a mean age of 21.09 years in the TECAR group and 21.63 years in the sham group. TECAR therapy was associated with significant reductions in pain intensity across all evaluation sessions. Specifically, after 5 sessions, there was a large effect size for pain reduction (p = 0.01); after 10 sessions, the effect was even larger (p = 0.001); and at the 1-month follow-up, the pain reduction persisted (p = 0.001). In terms of secondary outcomes, there was a significant improvement in hip adduction ROM at the 1-month follow-up (p = 0.03). Keywords: TECAR, Groin, Pain, Range of motion, Strength, HAGOS questionnaire